OneMedNet (NASDAQ:ONMD – Get Free Report) and Certara (NASDAQ:CERT – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.
Profitability
This table compares OneMedNet and Certara’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| OneMedNet | -584.20% | N/A | -521.20% |
| Certara | -16.75% | 3.86% | 2.65% |
Valuation & Earnings
This table compares OneMedNet and Certara”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| OneMedNet | $1.36 million | 28.45 | -$2.80 million | ($0.16) | -4.08 |
| Certara | $418.84 million | 2.75 | -$1.60 million | ($0.45) | -16.78 |
Certara has higher revenue and earnings than OneMedNet. Certara is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
OneMedNet has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Certara has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for OneMedNet and Certara, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
| Certara | 1 | 5 | 4 | 1 | 2.45 |
Certara has a consensus target price of $8.28, indicating a potential upside of 9.64%. Given Certara’s stronger consensus rating and higher possible upside, analysts plainly believe Certara is more favorable than OneMedNet.
Insider and Institutional Ownership
0.9% of OneMedNet shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 50.2% of OneMedNet shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Certara beats OneMedNet on 11 of the 15 factors compared between the two stocks.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
About Certara
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
